Watch the TV spot that may have patients asking about XIFAXAN.
Dr. Mark Pimentel
Executive Director, MAST Program at Cedars-Sinai Medical Center
Watch Dr. Pimentel discuss the diagnostic criteria for patients with IBS-D.
IBS-D = irritable bowel syndrome with diarrhea.
References: 1. Ford AC, Moayyedi P, Lacy BE, et al; Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(suppl 1):S2-S26. 2. Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376(26):2566-2578. 3. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407. 4. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-958.
Watch Dr. Pimentel and Dr. Brenner present information on the gut microbiota and IBS-D
Watch Dr. Pimentel, Dr. Brenner and Joscelyn Greaves, MSN, APRN-CNP, discuss different approaches used to manage IBS-D
See why Dr. Pimentel, Dr. Brenner and Joscelyn Greaves, MSN, APRN-CNP, think XIFAXAN FIRST
Watch Dr. Sayuk discuss bacterial imbalance and IBS-D, and treatment with XIFAXAN
Watch FNP Hanson discuss
IBS-D, patients’ lives, and XIFAXAN
Watch Dr. Moussa discuss diagnosing IBS-D and treating with XIFAXAN
Watch our latest consumer TV spot
Watch Dr. Pimentel discuss the efficacy and safety of XIFAXAN
Watch Dr. Pimentel discuss XIFAXAN dosing
Get information regarding XIFAXAN
Speak with a XIFAXAN representative
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.